|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks (restricted cash of $16,615 for both periods) | ||||||||||||||||||||
| Securities held-to-maturity, net of allowance of $338 and $348, respectively (assets pledged of $4,689 and $4,695, respectively; fair value of $45,212 and $46,232, respectively) | ||||||||||||||||||||
| Securities available for sale, at fair value (amortized cost of $1,633,466 and $1,387,619, respectively; net of an allowance of $2,774 and $2,921, respectively; assets pledged of $102,369 and $115,974, respectively; $14,527 and $14,412 at fair value pursuant to the fair value option, respectively) | ||||||||||||||||||||
| Collateralized Mortgage Backed Securities | ||||||||||||||||||||
| Other Debt Obligations | ||||||||||||||||||||
| Total securities available for sale, at fair value (amortized cost of $1,633,466 and $1,387,619, respectively; net of an allowance of $2,774 and $2,921, respectively; assets pledged of $102,369 and $115,974, respectively; $14,527 and $14,412 at fair value pursuant to the fair value option, respectively) | ||||||||||||||||||||
| Loans held for sale, at fair value | ||||||||||||||||||||
| Loans: | ||||||||||||||||||||
| Loans held for investment, net of fees and costs | ||||||||||||||||||||
| Less: Allowance for credit losses | ||||||||||||||||||||
| Construction Portfolio Segment | ||||||||||||||||||||
| Total less: Allowance for credit losses | ||||||||||||||||||||
| Net loans held of investment | ||||||||||||||||||||
| Interest and dividends receivable | ||||||||||||||||||||
| Bank premises and equipment, net | ||||||||||||||||||||
| Federal Home Loan Bank of New York stock, at cost | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangibles | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Non-interest bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total Due to depositors | ||||||||||||||||||||
| Mortgagors' escrow deposits | ||||||||||||||||||||
| Borrowed funds: | ||||||||||||||||||||
| Federal Home Loan Bank advances and other borrowings | ||||||||||||||||||||
| Subordinated debentures | ||||||||||||||||||||
| Junior subordinated debentures, at fair value | ||||||||||||||||||||
| Total borrowed funds | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Preferred stock ($0.01 par value; 5,000,000 shares authorized; none issued) | ||||||||||||||||||||
| Common stock ($0.01 par value; 100,000,000 shares authorized; 38,677,787 shares issued; 33,883,626 and 33,778,438 shares outstanding, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at average cost (4,794,161 and 4,899,349 shares, respectively) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income, net of taxes | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
